Baseline characteristics of in-person and virtually assessed patients age ≥75 years
| Variable . | In person (n = 870) . | Virtual (n = 110) . | P* . |
|---|---|---|---|
| Age, y | .763 | ||
| Mean | 79.57 | 79.45 | |
| SD | 4.04 | 3.75 | |
| Age group, y | .659 | ||
| 75-79 | 508 (58.4) | 64 (58.2) | |
| 80-84 | 254 (29.2) | 36 (32.7) | |
| 85-89 | 89 (10.2) | 9 (8.2) | |
| ≥90 | 19 (2.2) | 1 (0.9) | |
| Sex | .647 | ||
| Male | 546 (62.8) | 66 (60.0) | |
| Female | 324 (37.2) | 44 (40.0) | |
| Disease type | .407 | ||
| Leukemia | 271 (31.1) | 34 (30.9) | |
| Lymphoma | 298 (34.3) | 44 (40.0) | |
| Multiple myeloma | 301 (34.6) | 32 (29.1) | |
| Self-reported ECOG PS | .118 | ||
| 0 | 495 (56.9) | 63 (57.3) | |
| 1 | 252 (29.0) | 41 (37.3) | |
| 2 | 66 (7.6) | 5 (4.5) | |
| 3 | 48 (5.5) | 1 (0.9) | |
| 4 | 5 (0.6) | 0 (0.0) | |
| Missing | 4 (0.5) | 0 (0.0) | |
| Frailty (overall) | .322 | ||
| Robust | 223 (25.6) | 33 (30.0) | |
| Prefrail | 500 (57.5) | 64 (58.2) | |
| Frail | 147 (16.9) | 13 (11.8) | |
| Frailty (phenotype) | .082 | ||
| Robust | 250 (28.7) | 43 (39.1) | |
| Prefrail | 527 (60.6) | 57 (51.8) | |
| Frail | 93 (10.7) | 10 (9.1) | |
| Frailty (deficit accumulation) | .455 | ||
| Robust | 453 (52.1) | 64 (58.2) | |
| Prefrail | 294 (33.8) | 36 (32.7) | |
| Frail | 122 (14.0) | 10 (9.1) | |
| Missing | 1 (0.1) | 0 (0.0) |
| Variable . | In person (n = 870) . | Virtual (n = 110) . | P* . |
|---|---|---|---|
| Age, y | .763 | ||
| Mean | 79.57 | 79.45 | |
| SD | 4.04 | 3.75 | |
| Age group, y | .659 | ||
| 75-79 | 508 (58.4) | 64 (58.2) | |
| 80-84 | 254 (29.2) | 36 (32.7) | |
| 85-89 | 89 (10.2) | 9 (8.2) | |
| ≥90 | 19 (2.2) | 1 (0.9) | |
| Sex | .647 | ||
| Male | 546 (62.8) | 66 (60.0) | |
| Female | 324 (37.2) | 44 (40.0) | |
| Disease type | .407 | ||
| Leukemia | 271 (31.1) | 34 (30.9) | |
| Lymphoma | 298 (34.3) | 44 (40.0) | |
| Multiple myeloma | 301 (34.6) | 32 (29.1) | |
| Self-reported ECOG PS | .118 | ||
| 0 | 495 (56.9) | 63 (57.3) | |
| 1 | 252 (29.0) | 41 (37.3) | |
| 2 | 66 (7.6) | 5 (4.5) | |
| 3 | 48 (5.5) | 1 (0.9) | |
| 4 | 5 (0.6) | 0 (0.0) | |
| Missing | 4 (0.5) | 0 (0.0) | |
| Frailty (overall) | .322 | ||
| Robust | 223 (25.6) | 33 (30.0) | |
| Prefrail | 500 (57.5) | 64 (58.2) | |
| Frail | 147 (16.9) | 13 (11.8) | |
| Frailty (phenotype) | .082 | ||
| Robust | 250 (28.7) | 43 (39.1) | |
| Prefrail | 527 (60.6) | 57 (51.8) | |
| Frail | 93 (10.7) | 10 (9.1) | |
| Frailty (deficit accumulation) | .455 | ||
| Robust | 453 (52.1) | 64 (58.2) | |
| Prefrail | 294 (33.8) | 36 (32.7) | |
| Frail | 122 (14.0) | 10 (9.1) | |
| Missing | 1 (0.1) | 0 (0.0) |
Data are given as n (%) unless otherwise indicated.
SD, standard deviation.
A t test was performed to assess for a difference between the mean ages of patients who completed in-person and virtual assessments. χ2 tests were performed to assess for differences between in-person and virtual assessments in the distributions of age (as a categorical variable) and frailty status.